These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17082326)

  • 1. Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors.
    Rodrigo J; Pena A; Murat B; Trueba M; Durroux T; Guillon G; Rognan D
    Mol Endocrinol; 2007 Feb; 21(2):512-23. PubMed ID: 17082326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
    Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
    Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular localization and internalization of the vasopressin V1B receptor.
    Kashiwazaki A; Fujiwara Y; Tsuchiya H; Sakai N; Shibata K; Koshimizu TA
    Eur J Pharmacol; 2015 Oct; 765():291-9. PubMed ID: 26318147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor.
    Derick S; Pena A; Durroux T; Wagnon J; Serradeil-Le Gal C; Hibert M; Rognan D; Guillon G
    Mol Endocrinol; 2004 Nov; 18(11):2777-89. PubMed ID: 15284336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
    Oshikawa S; Tanoue A; Koshimizu TA; Kitagawa Y; Tsujimoto G
    Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.
    Sugimoto T; Saito M; Mochizuki S; Watanabe Y; Hashimoto S; Kawashima H
    J Biol Chem; 1994 Oct; 269(43):27088-92. PubMed ID: 7929452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single residue (arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists.
    Hawtin SR; Wesley VJ; Parslow RA; Simms J; Miles A; McEwan K; Wheatley M
    Mol Endocrinol; 2002 Mar; 16(3):600-9. PubMed ID: 11875119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
    Reymond-Marron I; Tribollet E; Raggenbass M
    Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.
    Mouillac B; Chini B; Balestre MN; Elands J; Trumpp-Kallmeyer S; Hoflack J; Hibert M; Jard S; Barberis C
    J Biol Chem; 1995 Oct; 270(43):25771-7. PubMed ID: 7592759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.
    Thibonnier M; Auzan C; Madhun Z; Wilkins P; Berti-Mattera L; Clauser E
    J Biol Chem; 1994 Feb; 269(5):3304-10. PubMed ID: 8106369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapituitary expression of the rat V1b vasopressin receptor gene.
    Lolait SJ; O'Carroll AM; Mahan LC; Felder CC; Button DC; Young WS; Mezey E; Brownstein MJ
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6783-7. PubMed ID: 7624319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide.
    Arai K; Kashiwazaki A; Fujiwara Y; Tsuchiya H; Sakai N; Shibata K; Koshimizu TA
    Eur J Pharmacol; 2015 Feb; 749():98-106. PubMed ID: 25592317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroanatomical distribution and function of the vasopressin V
    Corbani M; Marir R; Trueba M; Chafai M; Vincent A; Borie AM; Desarménien MG; Ueta Y; Tomboly C; Olma A; Manning M; Guillon G
    Gen Comp Endocrinol; 2018 Mar; 258():15-32. PubMed ID: 29155265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla.
    Grazzini E; Lodboerer AM; Perez-Martin A; Joubert D; Guillon G
    Endocrinology; 1996 Sep; 137(9):3906-14. PubMed ID: 8756565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin V1a and V1b receptors: from molecules to physiological systems.
    Koshimizu TA; Nakamura K; Egashira N; Hiroyama M; Nonoguchi H; Tanoue A
    Physiol Rev; 2012 Oct; 92(4):1813-64. PubMed ID: 23073632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic rat V1a vasopressin receptor fragments interfere with vasopressin binding via specific interaction with the receptor.
    Mendre C; Dufour MN; Le Roux S; Seyer R; Guillou L; Calas B; Guillon G
    J Biol Chem; 1997 Aug; 272(34):21027-36. PubMed ID: 9261104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
    Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
    Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.